Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

International Stem Cell (ISCO) Total Current Liabilities (2016 - 2025)

Historic Total Current Liabilities for International Stem Cell (ISCO) over the last 17 years, with Q3 2025 value amounting to $4.7 million.

  • International Stem Cell's Total Current Liabilities fell 133.53% to $4.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $4.7 million, marking a year-over-year decrease of 133.53%. This contributed to the annual value of $4.7 million for FY2024, which is 298.01% down from last year.
  • Latest data reveals that International Stem Cell reported Total Current Liabilities of $4.7 million as of Q3 2025, which was down 133.53% from $4.9 million recorded in Q2 2025.
  • In the past 5 years, International Stem Cell's Total Current Liabilities ranged from a high of $5.1 million in Q1 2025 and a low of $4.3 million during Q4 2021
  • Over the past 5 years, International Stem Cell's median Total Current Liabilities value was $4.7 million (recorded in 2024), while the average stood at $4.7 million.
  • Per our database at Business Quant, International Stem Cell's Total Current Liabilities skyrocketed by 18887.39% in 2021 and then crashed by 298.01% in 2024.
  • International Stem Cell's Total Current Liabilities (Quarter) stood at $4.3 million in 2021, then rose by 8.19% to $4.6 million in 2022, then rose by 4.25% to $4.8 million in 2023, then fell by 2.98% to $4.7 million in 2024, then fell by 0.7% to $4.7 million in 2025.
  • Its Total Current Liabilities was $4.7 million in Q3 2025, compared to $4.9 million in Q2 2025 and $5.1 million in Q1 2025.